Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip
Phase 2
- Conditions
- Hemophilia A With Inhibitor
- Interventions
- Drug: PEGylated Liposome (PEGLip)
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- Ascension Healthcare Development Limited
- Target Recruit Count
- 20
- Registration Number
- NCT04592692
- Locations
- 🇷🇺
Kemerovo District Clinical Hospital, Kemerovo, Russian Federation
🇷🇺Kirov Scientific Research Institute of Hematology and Blood Transfusion, Kirov, Russian Federation
🇷🇺National Medical Research Centre of Hematology, Moscow, Russian Federation
News
No news found